Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes
27 August 2021
ESC Premium Access
Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis
27 August 2021
ESC Premium Access
Intermittent therapy with levosimendan in patients with advanced heart failure